Cargando…

Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics

AIMS: Remodelling of the extracellular matrix (ECM) is a key mechanism involved in the development and progression of heart failure (HF) but also functional in associated pulmonary hypertension (PH). Our aim was to identify plasma ECM proteins associated to end‐stage HF and secondary PH in relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Abdulla, Ahmed, Salaheldin, Arvidsson, Mattias, Bouzina, Habib, Lundgren, Jakob, Rådegran, Göran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083509/
https://www.ncbi.nlm.nih.gov/pubmed/31858729
http://dx.doi.org/10.1002/ehf2.12560
_version_ 1783508550484492288
author Ahmed, Abdulla
Ahmed, Salaheldin
Arvidsson, Mattias
Bouzina, Habib
Lundgren, Jakob
Rådegran, Göran
author_facet Ahmed, Abdulla
Ahmed, Salaheldin
Arvidsson, Mattias
Bouzina, Habib
Lundgren, Jakob
Rådegran, Göran
author_sort Ahmed, Abdulla
collection PubMed
description AIMS: Remodelling of the extracellular matrix (ECM) is a key mechanism involved in the development and progression of heart failure (HF) but also functional in associated pulmonary hypertension (PH). Our aim was to identify plasma ECM proteins associated to end‐stage HF and secondary PH in relation to haemodynamics, before and after heart transplantation (HT). METHODS AND RESULTS: Twenty ECM plasma proteins were analysed with proximity extension assay in 20 controls and 26 HF patients pre‐HT and 1 year post‐HT. Right heart catherization haemodynamics were assessed in the patients during the preoperative evaluation and at the 1 year follow‐up post‐HT. Plasma levels of prolargin and matrix metalloproteinase‐2 (MMP‐2) were elevated (P < 0.0001) in HF patients compared with controls and decreased (P < 0.0001) post‐HT towards controls' levels. The decrease in prolargin post‐HT correlated with improved mean right atrial pressure (r (s) = 0.63; P = 0.00091), stroke volume index (r (s) = −0.73; P < 0.0001), cardiac index (r (s) = −0.64; P = 0.00057), left ventricular stroke work index (r (s) = −0.49; P = 0.015), and N‐terminal pro brain natriuretic peptide (r (s) = 0.7; P < 0.0001). The decrease in MMP‐2 post‐HT correlated with improved mean pulmonary artery pressure (r (s) = 0.58; P = 0.0025), mean right atrial pressure (r (s) = 0.56; P = 0.0046), pulmonary artery wedge pressure (r (s) = 0.48; P = 0.016), and N‐terminal pro brain natriuretic peptide (r (s) = 0.56; P = 0.0029). CONCLUSIONS: The normalization pattern in HF patients of plasma prolargin and MMP‐2 post‐HT towards controls' levels and their associations with improved haemodynamics indicate that prolargin and MMP‐2 may reflect, in part, the aberrant ECM remodelling involved in the pathophysiology of HF and associated PH. Their potential clinical use as biomarkers or targets for future therapy in HF and related PH remains to be investigated.
format Online
Article
Text
id pubmed-7083509
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70835092020-03-24 Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics Ahmed, Abdulla Ahmed, Salaheldin Arvidsson, Mattias Bouzina, Habib Lundgren, Jakob Rådegran, Göran ESC Heart Fail Original Research Articles AIMS: Remodelling of the extracellular matrix (ECM) is a key mechanism involved in the development and progression of heart failure (HF) but also functional in associated pulmonary hypertension (PH). Our aim was to identify plasma ECM proteins associated to end‐stage HF and secondary PH in relation to haemodynamics, before and after heart transplantation (HT). METHODS AND RESULTS: Twenty ECM plasma proteins were analysed with proximity extension assay in 20 controls and 26 HF patients pre‐HT and 1 year post‐HT. Right heart catherization haemodynamics were assessed in the patients during the preoperative evaluation and at the 1 year follow‐up post‐HT. Plasma levels of prolargin and matrix metalloproteinase‐2 (MMP‐2) were elevated (P < 0.0001) in HF patients compared with controls and decreased (P < 0.0001) post‐HT towards controls' levels. The decrease in prolargin post‐HT correlated with improved mean right atrial pressure (r (s) = 0.63; P = 0.00091), stroke volume index (r (s) = −0.73; P < 0.0001), cardiac index (r (s) = −0.64; P = 0.00057), left ventricular stroke work index (r (s) = −0.49; P = 0.015), and N‐terminal pro brain natriuretic peptide (r (s) = 0.7; P < 0.0001). The decrease in MMP‐2 post‐HT correlated with improved mean pulmonary artery pressure (r (s) = 0.58; P = 0.0025), mean right atrial pressure (r (s) = 0.56; P = 0.0046), pulmonary artery wedge pressure (r (s) = 0.48; P = 0.016), and N‐terminal pro brain natriuretic peptide (r (s) = 0.56; P = 0.0029). CONCLUSIONS: The normalization pattern in HF patients of plasma prolargin and MMP‐2 post‐HT towards controls' levels and their associations with improved haemodynamics indicate that prolargin and MMP‐2 may reflect, in part, the aberrant ECM remodelling involved in the pathophysiology of HF and associated PH. Their potential clinical use as biomarkers or targets for future therapy in HF and related PH remains to be investigated. John Wiley and Sons Inc. 2019-12-19 /pmc/articles/PMC7083509/ /pubmed/31858729 http://dx.doi.org/10.1002/ehf2.12560 Text en © 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Ahmed, Abdulla
Ahmed, Salaheldin
Arvidsson, Mattias
Bouzina, Habib
Lundgren, Jakob
Rådegran, Göran
Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title_full Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title_fullStr Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title_full_unstemmed Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title_short Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
title_sort prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083509/
https://www.ncbi.nlm.nih.gov/pubmed/31858729
http://dx.doi.org/10.1002/ehf2.12560
work_keys_str_mv AT ahmedabdulla prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics
AT ahmedsalaheldin prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics
AT arvidssonmattias prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics
AT bouzinahabib prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics
AT lundgrenjakob prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics
AT radegrangoran prolarginandmatrixmetalloproteinase2inheartfailureafterhearttransplantationandtheirassociationwithhaemodynamics